Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology.

Neurofibrillary tangles (NFTs) are composed of abnormal aggregates of the cytoskeletal protein tau. Together with amyloid beta (Abeta) plaques and neuronal and synaptic loss, NFTs constitute the primary pathological hallmarks of Alzheimer disease (AD). Recent evidence also suggests that caspases are activated early in the progression of AD and may play a role in neuronal loss and NFT pathology. Here we demonstrate that tau is cleaved at D421 (DeltaTau) by executioner caspases. Following caspase-cleavage, DeltaTau facilitates nucleation-dependent filament formation and readily adopts a conformational change recognized by the early pathological tau marker MC1. DeltaTau can be phosphorylated by glycogen synthase kinase-3beta and subsequently recognized by the NFT antibody PHF-1. In transgenic mice and AD brains, DeltaTau associates with both early and late markers of NFTs and is correlated with cognitive decline. Additionally, DeltaTau colocalizes with Abeta(1-42) and is induced by Abeta(1-42) in vitro. Collectively, our data imply that Abeta accumulation triggers caspase activation, leading to caspase-cleavage of tau, and that this is an early event that may precede hyperphosphorylation in the evolution of AD tangle pathology. These results suggest that therapeutics aimed at inhibiting tau caspase-cleavage may prove beneficial not only in preventing NFT formation, but also in slowing cognitive decline.

[1]  B. McLaughlin.  The kinder side of killer proteases: Caspase activation contributes to neuroprotection and CNS remodeling , 2004, Apoptosis.

[2]  F. LaFerla,et al.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer’s disease , 2003, Neurobiology of Aging.

[3]  C. Chung,et al.  Atypical role of proximal caspase-8 in truncated Tau-induced neurite regression and neuronal cell death , 2003, Neurobiology of Disease.

[4]  R. Nitsch,et al.  β-Amyloid Induces Paired Helical Filament-like Tau Filaments in Tissue Culture* , 2003, Journal of Biological Chemistry.

[5]  J. Troncoso,et al.  Caspase activation in the limbic cortex of subjects with early Alzheimer's disease , 2003, Annals of neurology.

[6]  P. Davies,et al.  Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms , 2003, Journal of neurochemistry.

[7]  M. Mattson,et al.  Triple-Transgenic Model of Alzheimer's Disease with Plaques and Tangles Intracellular Aβ and Synaptic Dysfunction , 2003, Neuron.

[8]  R. Berry,et al.  Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[9]  Bin Zhang,et al.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Berry,et al.  Inhibition of tau polymerization by its carboxy-terminal caspase cleavage fragment. , 2003, Biochemistry.

[11]  T. Utsumi,et al.  C‐terminal 15 kDa fragment of cytoskeletal actin is posttranslationally N‐myristoylated upon caspase‐mediated cleavage and targeted to mitochondria , 2003, FEBS letters.

[12]  I. Sponne,et al.  Apoptotic Neuronal Cell Death Induced by the Non-fibrillar Amyloid-β Peptide Proceeds through an Early Reactive Oxygen Species-dependent Cytoskeleton Perturbation* , 2003, The Journal of Biological Chemistry.

[13]  F. Barone,et al.  Caspase 3 activation is essential for neuroprotection in preconditioning , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Mandelkow,et al.  Toward a unified scheme for the aggregation of tau into Alzheimer paired helical filaments. , 2002, Biochemistry.

[15]  C. Cotman,et al.  Caspase Activation in the Alzheimer's Disease Brain: Tortuous and Torturous. , 2002, Drug news & perspectives.

[16]  P. Greengard,et al.  Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. , 2002, The American journal of pathology.

[17]  C. Cotman,et al.  Caspase-9 Activation and Caspase Cleavage of tau in the Alzheimer's Disease Brain , 2002, Neurobiology of Disease.

[18]  John Calvin Reed,et al.  Multiple caspases are activated after traumatic brain injury: evidence for involvement in functional outcome. , 2002, Journal of neurotrauma.

[19]  G. Cohen,et al.  DEDD regulates degradation of intermediate filaments during apoptosis , 2002, The Journal of cell biology.

[20]  J. Trojanowski,et al.  Transgenic Mouse Model of Tauopathies with Glial Pathology and Nervous System Degeneration , 2002, Neuron.

[21]  D. Geschwind,et al.  Human Wild-Type Tau Interacts with wingless Pathway Components and Produces Neurofibrillary Pathology in Drosophila , 2002, Neuron.

[22]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[23]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[24]  Caine W. Wong,et al.  Altered Metabolism of the Amyloid β Precursor Protein Is Associated with Mitochondrial Dysfunction in Down's Syndrome , 2002, Neuron.

[25]  A. LeBlanc,et al.  Selective cytotoxicity of intracellular amyloid β peptide1–42 through p53 and Bax in cultured primary human neurons , 2002, The Journal of cell biology.

[26]  H. Benveniste,et al.  Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema , 2002, Annals of neurology.

[27]  G. Johnson,et al.  Tau phosphorylation during apoptosis of human SH-SY5Y neuroblastoma cells , 2001, Brain Research.

[28]  William H. Nesse,et al.  Activation of Caspase-8 in the Alzheimer's Disease Brain , 2001, Neurobiology of Disease.

[29]  R. Nitsch,et al.  Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils , 2001, Science.

[30]  J. Hardy,et al.  Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP , 2001, Science.

[31]  Oliver Wirths,et al.  Intraneuronal Aβ accumulation precedes plaque formation in β-amyloid precursor protein and presenilin-1 double-transgenic mice , 2001, Neuroscience Letters.

[32]  I. Grundke‐Iqbal,et al.  Hyperphosphorylation induces self-assembly of τ into tangles of paired helical filaments/straight filaments , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Carl W. Cotman,et al.  Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology , 2001, Brain Research.

[34]  M. Vitek,et al.  Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. , 2001, Journal of cell science.

[35]  D. Jo,et al.  Proapoptotic Effects of Tau Cleavage Product Generated by Caspase-3 , 2001, Neurobiology of Disease.

[36]  J. Kuret,et al.  C-terminal inhibition of tau assembly in vitro and in Alzheimer's disease. , 2000, Journal of cell science.

[37]  J. Kuret,et al.  Oxidative regulation of fatty acid-induced tau polymerization. , 2000, Biochemistry.

[38]  E. Mandelkow,et al.  Nonsaturable Binding Indicates Clustering of Tau on the Microtubule Surface in a Paired Helical Filament-like Conformation* , 2000, The Journal of Biological Chemistry.

[39]  P. Davies,et al.  Conformational change as one of the earliest alterations of tau in Alzheimer’s disease , 2000, Neurobiology of Aging.

[40]  Patrick R. Hof,et al.  Tau protein isoforms, phosphorylation and role in neurodegenerative disorders 1 1 These authors contributed equally to this work. , 2000, Brain Research Reviews.

[41]  E B Mukaetova-Ladinska,et al.  Staging of cytoskeletal and beta-amyloid changes in human isocortex reveals biphasic synaptic protein response during progression of Alzheimer's disease. , 2000, The American journal of pathology.

[42]  G. Ugolini,et al.  The Neuronal Microtubule‐Associated Protein Tau Is a Substrate for Caspase‐3 and an Effector of Apoptosis , 2000 .

[43]  G. Ugolini,et al.  The neuronal microtubule associated protein tau is a substrate for caspase-3 and an effector of apoptosis , 2000, Neurobiology of Aging.

[44]  C. Cotman,et al.  Ultrastructural evidence of fibrillar β-amyloid associated with neuronal membranes in behaviorally characterized aged dog brains , 2000, Neuroscience.

[45]  J. Price,et al.  Formation of diffuse and fibrillar tangles in aging and early Alzheimer’s disease☆ , 2000, Neurobiology of Aging.

[46]  H. Buschke,et al.  Memory and mental status correlates of modified Braak staging , 1999, Neurobiology of Aging.

[47]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[48]  C. Cotman,et al.  Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8 , 1999, Neurobiology of Disease.

[49]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[50]  G. Jicha,et al.  Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease , 1999, Journal of neuroscience research.

[51]  C. Cotman,et al.  Multiple Pathways of Apoptosis in PC12 Cells , 1999, The Journal of Biological Chemistry.

[52]  E. Mandelkow,et al.  A nucleated assembly mechanism of Alzheimer paired helical filaments. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[53]  E. Mandelkow,et al.  Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease , 1998, The Journal of cell biology.

[54]  M. Mattson,et al.  Amyloid β-peptide induces apoptosis-related events in synapses and dendrites , 1998, Brain Research.

[55]  C. Barbato,et al.  Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis , 1998, The Journal of Neuroscience.

[56]  M. Mattson,et al.  Evidence for Synaptic Apoptosis , 1998, Experimental Neurology.

[57]  H. Vinters,et al.  Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. , 1998, The American journal of pathology.

[58]  G. Jicha,et al.  Alz‐50 and MC‐1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau , 1997, Journal of neuroscience research.

[59]  J. Kuret,et al.  The Structural Basis of Monoclonal Antibody Alz50's Selectivity for Alzheimer's Disease Pathology* , 1996, The Journal of Biological Chemistry.

[60]  Brian J Cummings,et al.  β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.

[61]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[62]  Seamus J. Martin,et al.  Proteolysis of Fodrin (Non-erythroid Spectrin) during Apoptosis (*) , 1995, The Journal of Biological Chemistry.

[63]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[64]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[65]  E. Mandelkow,et al.  Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: Distinction between PHF-like immunoreactivity and microtubule binding , 1993, Neuron.

[66]  J. Trojanowski,et al.  The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[67]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[68]  J. Kabat,et al.  Molecular characterization of the minimal protease resistant tau unit of the Alzheimer's disease paired helical filament. , 1993, The EMBO journal.

[69]  A. Hyman,et al.  Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau. , 1992, Molecular biology of the cell.

[70]  P. Davies,et al.  Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. , 1992, The Journal of biological chemistry.

[71]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[72]  K. Kosik,et al.  Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons , 1990, Nature.

[73]  J. Trojanowski,et al.  Epitopes that span the tau molecule are shared with paired helical filaments , 1988, Neuron.

[74]  A. Klug,et al.  Structural characterization of the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[75]  H. Wiśniewski,et al.  Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. , 1986, The Journal of biological chemistry.

[76]  A. Wyllie,et al.  Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.

[77]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[78]  M. Vitek,et al.  Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[79]  T. Bayer,et al.  Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. , 2001, Neuroscience letters.

[80]  J. Trojanowski,et al.  Neurodegenerative tauopathies. , 2001, Annual review of neuroscience.

[81]  C. Cotman,et al.  Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease. , 2001, The American journal of pathology.

[82]  P. Greengard,et al.  Intraneuronal Abeta42 accumulation in human brain. , 2000, The American journal of pathology.

[83]  P. Greengard,et al.  Intraneuronal Aβ42 Accumulation in Human Brain , 2000 .

[84]  C. Cotman,et al.  Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. , 1999, Neurobiology of disease.

[85]  G. Robertson,et al.  Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. , 1999, Cell.

[86]  E. Tangalos,et al.  Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .

[87]  M. Mattson,et al.  Amyloid beta-peptide induces apoptosis-related events in synapses and dendrites. , 1998, Brain research.

[88]  Brian J Cummings,et al.  Beta-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. , 1996, Neurobiology of aging.